Bioremediation Pioneer Stephen S. Koenigsberg, Ph.D., Joins Environmental Strategies Consulting LLC

Reston, VA (PRWEB) February 3, 2006

Environmental Strategies Consulting LLC, the environmental consulting services subsidiary of Quanta Capital Holdings Ltd. (NASDAQ: QNTA), today announced that Stephen S. Koenigsberg, Ph.D., a pioneer in the development and commercialization of advanced bioremediation and chemical oxidation technologies, has joined the company as a Partner and head of its new Irvine, California office. Dr. Koenigsberg was Vice President for Research and Development at San Clemente, CA-based Regenesis, Inc., which he co-founded in 1994 as Regenesis Bioremediation Products. Through Dr. Koenigsberg, Environmental Strategies will be providing consulting services to Regenesis. Dr. Koenigsberg remains Chairman of Regenesis’ Science Advisory Board.

At Environmental Strategies, Dr. Koenigsberg will focus on groundwater and soil remediation using conventional bioremediation and chemical oxidation technologies. He will also lead the firm’s activities in environmental biotechnology and advanced chemical diagnostics. These are emerging areas that are poised to lead to dramatic time- and cost-saving advances in the evaluation, treatment and regulatory disposition of contaminated sites as well as for improving methods for prevention of environmental problems.

“Steve is unquestionably among the leaders in bioremediation and chemical oxidation, and his innovations in the field have helped redefine and advance the way sites are cleaned up throughout the world,” said Jan Chizzonite, of Environmental Strategies. “We are looking forward to working with Steve as Environmental Strategies continues to support our client’s needs for timely, effective, and cost efficient environmental services.”

An active researcher and educator, Dr. Koenigsberg serves as an Adjunct Professor at the California State University at Fullerton and the University of California at Irvine. He has authored or co-authored four books and over 130 articles and holds four U.S. patents for advancements in bioremediation technology. He led the development of Regenesis’ industry-leading proprietary products, including Oxygen Release Compound (ORC®), Hydrogen Release Compound (HRC®), RegenOxtm and a series of environmental biotechnology products, which have been successfully used on over 14,000 sites worldwide.

“Environmental Strategies is a growing business with terrific expertise across its entire organization, and I’m looking forward to being a part of the company,” said Dr. Koenigsberg. “Environmental Strategies is clearly at the forefront of the latest methods and technologies for quickly and effectively supporting their clients’ EHS needs, and that foundation of superior client service balanced with top-notch engineering, was of natural appeal for me.”

About Environment Strategies Consulting LLC

Established in 1986, Reston, VA-based Environmental Strategies Consulting is a full-service firm providing investigation, remediation and engineering services, assessment services, information management services and other technical services in the environmental area. Environmental Strategies has 15 offices throughout the U.S., serving private-sector clients throughout the world. Environmental Strategies is a subsidiary of Quanta Capital Holdings Ltd, a Bermuda-based company that provides specialty insurance, specialty reinsurance, and risk assessment and consulting services. For further information, please visit Environmental Strategies online at http://www.environmental-strategies.com.

About Quanta Capital Holdings Ltd.

Quanta Capital Holdings Ltd., a Bermuda holding company, provides specialty insurance, specialty reinsurance, and risk assessment and consulting services through its subsidiaries. Through operations in Bermuda, the United States, Ireland and the United Kingdom, Quanta focuses on writing coverage for specialized classes of risk through a team of experienced, technically qualified underwriters. The company offers specialty insurance and reinsurance products that often require extensive technical underwriting skills, risk assessment resources and engineering expertise. Quanta is listed on the NASDAQ stock market and trades under the symbol QNTA.

The statements contained in this press release may include forward-looking statements within the meaning of the federal securities law. Although the company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be achieved. As forwardlooking statements, these statements involve risks, uncertainties and other factors that could cause actual results to differ materially from the expected results. These factors are detailed in the company's filings with the U.S. Securities and Exchange Commission. The company assumes no obligation to update or supplement forward-looking statements to reflect subsequent events or circumstances.

Editor please note: a high-resolution digital photo of Dr. Koenigsberg is available on request

###